Table 1.
Lesion
|
Location
|
T1-WI
|
T2-WI
|
Cine-SSFP
|
Perfusion
|
EGE
|
LGE
|
|
Non-neoplastic | ||||||||
Thrombus Acute/subacute | Mural or intraluminal | Iso-Hyper | Iso-Hyper | Iso-hypo | No enhancement | No enhancement | Hypointense border and brighter central zone | |
Thrombus Chronic | Mural or intraluminal | Hypo | Hypo | Iso-hypo | Rare | No enhancement | Rarely heterogeneous | |
Pericardial cyst | Right cardiophrenic angle | Hypo | Hyper | Hyper | No enhancement | No enhancement | No enhancement | |
Mitral annular calcification | Annular fibrous ring of the left atrio-ventricular valve | Hypo | Hypo | Iso-hypo | No enhancement | Peripheral rim of enhancement | Peripheral rim of enhancement | |
Liquefaction necrosis | Annular fibrous ring of the left atrio-ventricular valve | Mildly Hyper | Mildly Hyper | Iso-hypo | No enhancement | Peripheral rim of enhancement | Peripheral rim of enhancement +/- core enhancement | |
Neoplastic - Benign | ||||||||
Myxoma | Left atrium, arising from the interatrial septum | Iso (heterogeneous) | Hyper (heterogeneous) | Hypo | Heterogeneous | Heterogeneous | Heterogeneous | |
Papillary fibroelastoma | Atrial side of the mitral valve and the aortic surface of the aortic valve leaflet | Iso | Iso | Hypo | Usually not assessable | Mild and homogeneous or no enhancement | Homogeneous or no enhancement | |
Lipoma | Atrial septum and epicardium, but it may occur anywhere in the heart | Hyper | Hyper (Hypo on STIR images) | Hyper (with black boundary artifact or India ink artifact) | No enhancement | No enhancement | No enhancement | |
Hemangioma | Every cardiac chamber and also from pericardial space | Iso | Hyper | Hyper | Heterogeneous, intense and prolonged | Homogeneous or heterogeneous | Homogeneous or heterogeneous | |
Fibroma | Intramural growth in the ventricles (interventricular septum or the ventricular free wall) | Iso | Hypo | Iso-hypo | Mild and homogeneous | Mild and homogeneous | No enhancement or minimal uptake | |
Rhabdomyoma | Intramyocardial or intracavitary, with intraventricular growth that may cause outflow obstruction | Iso | Mildly Hyper | Iso-hypo | No enhancement or minimal uptake | No enhancement or minimal uptake | No enhancement or minimal uptake | |
Cardiac teratomas | Intrapericardial (usually compressing superior vena cava and/or right atrium) | Iso or Hypo | Hyper | Iso or Slightly hyper | No enhancement | Mild and heterogeneous | Heterogeneous | |
Paraganglioma | On the roof of left atrium | Iso-Hypo with “salt and pepper” appearance | Hyper with “salt and pepper” appearance | Hyper | Strong enhancement | Heterogeneous Peripheral | Heterogeneous Peripheral | |
Neoplastic - malignant: Primary cardiac tumor | ||||||||
Angiosarcoma | Right atrium close to atrio-ventricular sulcus | Iso-Hyper (heterogeneous) | Hyper (heterogeneous) | Iso (heterogeneous) | Strong enhancement | Marked and Heterogeneous | Marked and Heterogeneous | |
Leiomyosarcoma | Typically involve the left atrium | Iso | Iso-Hyper | Iso | Heterogeneous, intense | Marked and Heterogeneous | Marked and Heterogeneous | |
Rhabdomyosarcoma | Multiple masses and there is not any predilection in terms of cardiac structures involved | Iso | Iso-Hyper (hyper on STIR images) | Iso | Heterogeneous, intense | Marked and Heterogeneous | Marked and Heterogeneous | |
Lymphoma | Right chambers, often right ventricle and are associated with pericardial effusion | Hypo-Iso | Mildly Hyper (more evident on STIR images) | Iso | Mild | Heterogeneous | No or progressive mild heterogeneous enhancement | |
Mesothelioma | Pericardium | Iso | Hyper (heterogeneous) | Iso | Progressive enhancement | Intense enhancement | Intense enhancement | |
Malignant - Malignant: metastatic disease | Mainly involve myocardium and pericardium | Low (except for Melanoma which is Hyper) | Hyper | Iso | Heterogeneous | Heterogeneous | Heterogeneous |
T1-WI: T1-weighted images; T2-WI: T2-weighted images; STIR: Short tau inversion recovery; Cine-SSFP: Cine-steady state free precession; EGE: Early gadolinium enhancement; LGE: Late gadolinium enhancement; Hypo: Hypointense; Iso: Isointense; Hyper: Hyperintense.